AVIVA PLC

Position in AZN — Astrazeneca PLC

CIK 1140022 LONDON, X0

Position in AZN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$2,186,708,502

New position

Shares Held

11,087,661

first reported quarter

Ownership

0.715%

of shares outstanding

% of Portfolio

3.78%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AVIVA PLC holds $4,673,816,581 across 10 Drug Manufacturers - General names. AZN ranks #1 (46.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC This page	11,087,661	$2,186,708,502
2	LLY	ELI LILLY & Co	712,581	$655,410,626
3	JNJ	Johnson & Johnson	2,132,397	$521,243,122
4	MRK	Merck & Co., Inc.	3,236,573	$389,327,366
5	ABBV	AbbVie Inc.	1,531,018	$332,981,104
6	GILD	Gilead Sciences, Inc.	1,174,576	$163,700,657
7	AMGN	Amgen Inc	464,183	$163,322,788
8	PFE	Pfizer Inc	4,849,934	$136,186,146

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,186,708,502	11,087,661	—	Shares	Defined	2026-05-14
No filing history on record for this holder in this stock.